ATYR / aTyr Pharma, Inc. - Ai+ Enhanced Message Board

aTyr Pharma, Inc.
US ˙ NasdaqCM ˙ US0021202025

aTyr Pharma, Inc. - Latest Posts

All of our community channels are now AI enhanced. This means that you can ask our AI agent questions within the message board and get answers directly. To try it out, join a channel, ask your question, and click the Ask AI button.

Discussions with AI Participation are marked with Ai+ .

This page shows the latest posts for the aTyr Pharma, Inc. channel.

Johnny 05-16 Welcome
US:ATYR

Dear Fintel Team, I’m writing to bring to your attention a significant data integrity issue regarding the way Octagon Capital Advisors LP’s Q1 2025 13F-HR filing is being displayed on your platform for aTyr Pharma, Inc. (NASDAQ: ATYR). Your site currently shows: • Position Value: $5.7M • Shares Held: 10,000,000 • Share Price at Filing: $0.57 This is not only inconsistent with the official 13F-HR XML data filed with the SEC (Accession Number: 0001839435-25-000004), but also mathematicall...

Share Your Thoughts or Ask a Question
Dicci cosa hai da dire. Puoi includere link, ma non *solo* link. Condividi le tue opinioni ponderate. Usa Markdown .
Using Standard
Other Listings
DE:471A 4,72 €
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista